Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Clinical electrophysiological and hemodynamic effects of BRL-32872A

June 2, 1997

New i.v. formulation of amiodarone better tolerated in patients

June 2, 1997

AMBI reports positive results for Cardia Salt Alternative

June 2, 1997

Carvedilol approved by FDA for CHF

May 30, 1997

New agents for atherosclerosis from Bayer

May 30, 1997

Yamanouchi discloses Na+/H+ exchange inhibitors

May 30, 1997

Preliminary results from phase I trial of Nortran's RSD-921 reported

May 30, 1997

Use of labetalol in renal transplant patients discouraged

May 28, 1997

Clevidipine for controlling hypertension after CABG

May 27, 1997

ET antagonists disclosed by Merck KGaA

May 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld Science
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...